Australia markets closed

Connect Biopharma Holdings Limited (CNTB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.5200+0.0900 (+6.29%)
As of 12:30PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
51,913
51,913
96,630
80,496
23,102
Selling general and administrative
14,515
14,515
20,806
19,014
7,304
Total operating expenses
64,848
64,848
116,507
96,560
29,336
Operating income or loss
-64,848
-64,848
-116,507
-96,560
-29,336
Interest expense
23
23
21
7
6.4286
Total other income/expenses net
2,774
2,774
-2,809
-105,530
-89,600
Income before tax
-59,383
-59,383
-117,793
-202,000
-119,270
Income tax expense
120
120
298
266
0
Income from continuing operations
-59,503
-59,503
-118,091
-202,266
-119,270
Net income
-59,503
-59,503
-118,091
-202,266
-119,270
Net income available to common shareholders
-59,503
-59,503
-118,091
-202,266
-119,270
Basic EPS
-11.10
-
-2.10
-3.92
-2.21
Diluted EPS
-11.10
-
-2.10
-3.92
-2.21
Basic average shares
55,037
-
54,969
52,273
53,942
Diluted average shares
55,037
-
54,969
52,273
53,942